Translational research is the essential link between basic research and clinical research.
In a few words, translational research consists in moving, transporting and transmitting, as quickly as possible, scientific innovations towards better patient care: the evaluation and validation of diagnostic, prognostic and patient monitoring tools, as well as the development of biomedical devices or therapeutic approaches resulting from fundamental research.
Role of the King Albert II Institute in Translational Research
The transfer of innovative therapeutic approaches to patients is the result of advances in medical research (fundamental, clinical, therapeutic and public health).
The King Albert II Institute is positioned on the entire pathway from the research laboratory to the patient's bed.
This pathway is complex.
The role of the King Albert II Institute is to encourage multidisciplinary research and to bring together the various scientific and hospital players, among other things through the creation of national and international research networks and the setting up of new infrastructures.
It is also a privileged partner for drug manufacturers, medical technology and biotechnology companies.
This dynamic collaboration is essential in the field of translational research, which remains costly and often too dispersed.